TICO-ACS Substudy: Ticagrelor Monotherapy After Short-Term DAPT Reduces Major Bleeding Events Without Increase in Ischemic Events in STEMI
Ticagrelor monotherapy after short-term dual antiplatelet therapy (DAPT) reduces major bleeding events without increasing ischemic events in patients with ST-segment elevation myocardial infarction (STEMI), according to a substudy from the TICO ACS trial released Monday.